THE THERAPEUTIC VALUE of coronary arterial bypass grafting is suggested by many favorable reports which stress particularly the relief of angina pectoris.' However, definitive statements regarding the effectiveness of this procedure in improving myocardial function, preventing myocardial necrosis and death from myocardial disease, and in producing permanent (or sustained) relief of angina are not possible at present, in our opinion. In this presentation, we shall review our own experience with coronary arterial bypass grafting procedures in 548 patients against the background of information available from other centers, and from our own experience with patients treated medically.
Natural History of Coronary Atherosclerosis
At one time aorta to femoral and femoral to popliteal arterial bypass grafting procedures were recommended to patients with intermittent claudication and significant atherosclerotic occlusive disease in these vessels as prophylaxis against loss of limb. We now recognize that most patients with intermittent claudication do not develop gangrenous limbs, and that with some exceptions, these operations are done principally for relief of symptoms. Knowledge of the natural history of the occlusive disease is obviously necessary to assess the potential benefits of surgical therapy of that disease.
Information about the natural history of coronary atherosclerosis has been available for about 20 years.
In general, the five-year survival rates for patients with angina pectoris have been in the range of 65-80%, that is, an annual death rate of 4 to 7% f8 With the development of coronary arteriography it has become possible to identify subgroups of patients who are at varying degrees of risk for death from myocardial infarction. This risk is dependent primarily on the extent of coronary atherosclerosis and on the severity of structural damage to the left ventricular myocardium. [9] [10] [11] [12] In our center, coronary arteriography was frequently performed between 1965 and 1970, but few patients were advised to have operations during this period. The subsequent course of the patients who had coronary arteriography during this period has been determined by detailed follow-up study."0 Among 246 patients followed an average of 21 months following coronary arteriography, mortality was directly related to the number of coronary vessels with greater than 50% obstruction of the intraluminal diameter, to the presence of symptoms of congestive failure, and to heart size, the latter implying significant left ventricular dysfunction (table 1). The mortality was lowest among patients with disease of no or one vessel without symptoms of congestive failure, and was highest among patients with disease of two or three vessels with symptoms of failure.
More recently, a larger series of 590 patients with coronary atherosclerosis managed without operation and followed from five to nine years following coronary arteriography and left ventriculography has been reported. "' 12 These studies confirm the favorable prognosis of occlusive disease confined to a single vessel noted previously by Freisinger et al. ' and Oberman et al.'0 and the more unfavorable prognosis of involvement of two vessels, obstruction of the left main coronary artery, and involvement of three vessels ( fig. 1 ). Combining the results of coronary arteriography and left ventriculography yielded a better prediction of survival than either method separately. 12 Survival was considerably diminished when ventricular aneurysms or diffuse contractile abnormalities were present. Data on the incidence of Survival curves for individual arteriographic categories. Cases with one-vessel involvement were divided into cases with and without additional moderate (>30% and <50%) narrowings. For cases with one-vessel disease without additional narrowings the survival curve for cardiac death only is also given (interrupted line); in the other cases the influence of noncardiac deaths was practically negligible. (Reproduced with permission from"). coronary artery, 26% in patients with disease of three vessels, and 9% in patients with disease of one or two vessels. One hundred and eight (33%) of the survivors had no chest pain at the end of the follow-up period.
Results of Coronary Artery Bypass Grafting
In the absence of prospective randomized studies, the results of coronary bypass grafting procedures can be properly assessed only by comparison of surgically treated patients with patients managed nonoperatively who have similar symptoms and degrees of coronary atherosclerosis and left ventricular dysfunction.
Early Results
Data from several centers have demonstrated that coronary bypass grafting procedures can be performed with a low hospital mortality rate (less than 5%) unless there is appreciable impairment of left ventricular function (i.e., diffuse scarring or aneurysm). 1, 45, 1, 114 In our own series, the operative mortality for 517 patients with angina pectoris and normal or moderately impaired left ventricular function has been 1.9% (10 patients). This group includes 50 patients with unstable angina pectoris and 67 patients having concomitant aortic, mitral, or double valve replacement. Among patients with severe left ventricular dysfunction and symptoms of cardiac failure, the mortality has been appreciably higher (table 2). The risk of operation has not been enhanced by multiple grafting procedures (table 3) .
Electrocardiographic evidence of acute myocardial infarction early postoperatively has been reported in from 7 to 20% of patients following coronary bypass procedures.4 6 16 In a consecutive series of 151 patients included in our over-all group of 548 patients, who received only coronary arterial bypass grafts and who were evaluated with serial electrocardiograms and serum enzyme analyses, 15 patients (9.9%) developed Q waves indicative of acute infarction postoperatively. An additional 34 patients (22%) developed significant ST-T wave changes without new Q waves suggesting significant myocardial injury.'`In this group, the presence of previous infarction, the severity of coronary arterial obstruction, and the number of vessels bypassed did not correlate directly with the incidence of postoperative myocardial injury. Oldham et al. 17 have noted isoenzymatic evidence of myocardial cell injury following coronary arterial bypass grafting in approximately 80% of patients, suggesting that myocardial injury occurs more frequently than is apparent electrocardiographically. In quite another setting, following aortic valve replacement, we have observed an incidence of electrocardiographic evidence of infarction of 13% (7 of 64 patients) and isoenzymatic evidence of myocardial cell injury in 83% of patients (40 of 48).18 Thus, production of diffuse structural myocardial damage in the majority of patients after such operations may be inherent in the present techniques of cardiopulmonary bypass. The effect of this injury on the long term results of coronary bypass surgery is uncertain, particularly since the likelihood of further myocardial necrosis is higher than in patients following operation for other types of heart disease.
Late Results
The critical questions regarding the late results of bypass grafting procedures include the long term function of the grafts, and the effects of functioning Several studies have shown that 70 to 80% of saphenous vein bypass grafts are patent one to three years after operation.19' 20 Higher patency rates have been reported using the internal mammary artery which has been anastomosed primarily to the anterior descending artery. 21 22 In our own experience with vein bypass grafts, patency rates approximately one year following operation have been highest in grafts to the anterior descending artery (80%), with an overall patency rate of 75% (table 4) .
Flow through vein grafts measured at the time of operation correlates well with subsequent patency. Flows of less than 40 ml/min are associated with significantly higher occlusive rates than when flows greater than this are measured and this is no doubt related to the size of the distal vessels and the severity of atherosclerotic disease present in them.19' 23. 24 As factors affecting late patency rates are identified, better case selection may become possible.
Angina pectoris is completely or partially relieved for at least several years in 60 to 80% of patients following operation.2 In light of the known significant incidence of structural myocardial damage occurring early postoperatively, it cannot be assumed that this is entirely the result of increased myocardial blood flow through functioning grafts. However, good correlations between graft patency and clinical response have been observed by others" and by us (table 5). The completeness of revascularization also appears to influence the degree of symptomatic improvement. Sheldon et al. 25 reported complete relief of symptoms in 85% of patients with complete revascularization, and in 33% of patients in whom no grafts were functioning.
Whether or not the relief of angina will be sustained is uncertain at present. Careful follow-up examination of a series of patients in our institution suggests that the relief of angina may not be permanent following bypass grafting procedures ( fig. 2 ). This may be the result of additional graft failures, progression of cor- Figure 2 Change in angina pectoris following coronary bypass grafting. onary atherosclerosis, or both. Similar findings have been noted by Adam et al. 26 Objective data on improvement in exercise tolerance following bypass grafting indicate good correlations between this parameter and graft patency and/or symptomatic improvement.27 29 Significant ST segment changes suggestive of ischemia persisted in a number of these patients, however. The data of Lapin et al.29 comparing exercise and hemodynamic variables in patients with patent and occluded grafts are shown in table 6. There was significant improvement in oxygen consumption, duration of exercise and maximal heart rate achieved among patients with all grafts patent, which was not noted in patients with no grafts patent. No changes in systolic ejection fraction, left ventricular end-diastolic pressure, or cardiac index were observed in any of the patients. Among nine patients with a depressed ejection fraction (<50%) preoperatively, none showed improvement in exercise performance eight months 'postoperatively.
Few data are available at present to demonstrate the beneficial effects of bypass grafting on prevention of myocardial necrosis and survival. Sheldon et al. 25 have recently published data purported to show such an effect in 1000 patients treated surgically who were compared to 526 patients treated without operation but with comparable degrees of atherosclerosis. Both the surgical and nonsurgical groups contained a relatively high proportion of patients with single vessel disease (38% and 36% respectively), and the breakdown into those with isolated disease and associated moderate narrowings in other vessels is not given. Some confusion is also lent by the fact that well over half the patients in the series (528 of 619 restudied) received only single grafts. In addition, the data are not presented so that the specific surgical survival rates of patients with double and triple vessel disease can be determined. A true difference in survival between the surgical and medical groups was not established in patients with single vessel involvement.
In the first two years, late death was less common in the surgical than in the nonsurgical group (fig. 3 ). However after two years, the slopes of the lines were similar.
In a study of 53 patients with high grade stenoses or total occlusion of the left anterior descending coronary artery, we have observed a higher incidence of postoperative and late myocardial infarction (17%) among 29 patients treated by vein bypass grafting than in the 24 patients managed without operation (4%). Survival was not enhanced by bypass grafting in a mean follow-up period of 29 months. Complete relief of angina and improvement in exercise testing were greater in the surgically treated patients however.30
Indications for Operation
From the above information and our own surgical experience, we conclude that patients with severe angina pectoris and two or three vessel involvement (including left main coronary lesions) but absence of significant narrowings in other vessels have a good prognosis and operation, we believe, should not be recommended unless they have failed to respond to appropriate medical therapy.
Conclusions
In summary, we know some things about coronary artery bypass grafting. The hospital mortality rate is low for patients without significant structural myocardial damage. New myocardial damage following operation is probably produced to some degree in most patients. Approximately 75% of saphenous vein grafts are patent one to three years after operation. This patency rate may be increased by better selection of patients and possibly by increased use of the internal mammary artery graft. Relief of symptoms and improved hemodynamic response to exercise testing usually result for at least several years in patients with patent grafts who preoperatively had minimal structural myocardial damage. Survival rates may be improved in such patients for several years after operation, but the long term survival will probably be strongly influenced by the basic disease process atherosclerosis. Clearly we all have much to do to clarify the effectiveness of medical and surgical therapy of this disease. Therein lies our dilemma but also our challenge and opportunity.
